Tower Research Capital LLC (Trc) Point Biopharma Global Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.67 - $9.71 $28,807 - $41,937	-4,319 Reduced 62.21%	2,624 $17,000
Q2 2023 Aug 14, 2023	BUY	$6.86 - $10.86 $26,493 - $41,941	3,862 Added 125.35%	6,943 $62,000
Q1 2023 May 09, 2023	BUY	$6.78 - $8.1 $9,085 - $10,854	1,340 Added 76.97%	3,081 $22,000
Q4 2022 Feb 10, 2023	SELL	$5.72 - $9.78 $52,292 - $89,408	-9,142 Reduced 84.0%	1,741 $13,000
Q3 2022 Nov 10, 2022	SELL	$7.24 - $10.31 $4,778 - $6,804	-660 Reduced 5.72%	10,883 $84,000
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $64,640 - $109,658	11,543 New	11,543 $79,000
Q1 2022 May 12, 2022	SELL	$5.46 - $8.13 $44,575 - $66,373	-8,164 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.83 - $9.75 $20,783 - $41,954	4,303 Added 111.45%	8,164 $46,000
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $28,648 - $43,474	3,861 New	3,861 $30,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.